A 46-year-old patient described her situation to me almost word for word the way I have heard it described a hundred times. She had gained 22 pounds over four years. The weight had landed almost entirely in her midsection — her arms and legs looked the same, her face looked the same, but her waistline had thickened in a way she could not explain. She was eating less than she had in her thirties. She was walking more. She had cut alcohol back to the occasional weekend glass of wine. None of it had moved the scale, and the shape change had progressed even when the scale held steady. She had been told by two prior providers that this was menopause, that this was aging, and that she should accept it.
Her labs told a different story. Fasting insulin of 18 mIU/L. HOMA-IR of 3.8. Morning cortisol of 24 mcg/dL. Estradiol that had dropped into the perimenopausal range. Free testosterone below the assay floor. Reverse T3 elevated. Vitamin D at 21. Every one of those numbers was contributing to the central weight gain, and every one was treatable. The "just menopause" diagnosis was not wrong about the trigger. It was wrong about the conclusion that nothing could be done.
This is the picture I want to dig into, because cortisol-driven central fat is one of the most misunderstood metabolic situations I see — both by patients and by the providers who tell them to eat less and try harder.
What cortisol actually does to fat distribution
Cortisol is the body's primary stress hormone. In an acute stress response, cortisol mobilizes glucose, suppresses non-essential systems like reproduction and digestion, and primes the body for action. It is supposed to spike, do its job, and come back down. The problem is when it does not come back down — when chronic stress, poor sleep, blood sugar instability, or HPA axis dysfunction keeps cortisol elevated for months and years at a time.
Chronically elevated cortisol does several things that drive central adiposity specifically. It stimulates hepatic gluconeogenesis — the liver produces glucose even when blood sugar is already adequate, which forces the pancreas to release more insulin to clear it. The combination of elevated cortisol and elevated insulin is a uniquely effective signal for visceral fat storage, because visceral adipocytes have a higher density of cortisol receptors than subcutaneous fat. Cortisol also suppresses peripheral lipolysis (fat breakdown) while promoting central fat deposition. The body literally redistributes fat from the limbs to the abdomen under sustained cortisol pressure.
There is a secondary mechanism that matters even more long-term. Visceral fat is not inert. It is metabolically active tissue that produces its own inflammatory cytokines and contains the enzyme 11-beta-HSD1, which converts inactive cortisone back into active cortisol locally. Visceral fat creates more cortisol, which creates more visceral fat, which creates more cortisol. The system feeds itself, and the longer it runs, the harder it gets to interrupt without addressing the upstream drivers.
Why insulin resistance is almost always part of this picture
Cortisol does not work alone. Chronic cortisol elevation directly produces insulin resistance — at the muscle, the liver, and the adipose tissue. Insulin-resistant cells require more insulin to clear the same amount of glucose, so fasting insulin climbs. Elevated insulin is the primary signal for fat storage and against fat mobilization. The patient ends up in a state where their body is producing constant fat-storage signaling regardless of how much they eat or how much they exercise.
This is the piece that gets missed in conventional weight loss advice. A caloric deficit in an insulin-sensitive person produces fat loss because the body is willing to mobilize stored fat for fuel. A caloric deficit in an insulin-resistant, cortisol-elevated person produces hunger, fatigue, and muscle loss while preserving fat — because the hormonal signaling is telling the body to hold the fat at all costs. The patient feels like they are doing everything right and getting punished for it, and they are not wrong.
Standard panels miss this because fasting glucose stays normal for years while fasting insulin climbs. The patient's HbA1c is normal, their fasting glucose is normal, their lipid panel might even look acceptable, and the conclusion is "metabolically healthy" — when in fact they are deep into the early phase of metabolic dysfunction that will show up clinically in a decade if it is not addressed now.
Where sex hormones fit in the picture
Estrogen and testosterone are not separate from this conversation. Estrogen, in women, has direct effects on fat distribution — it favors gluteofemoral storage in younger women and shifts toward central storage as it declines through perimenopause. Estrogen also supports insulin sensitivity. Its decline is a meaningful contributor to the metabolic shift that almost every perimenopausal patient experiences.
Testosterone, in both sexes, supports lean mass and insulin sensitivity. Its decline accelerates fat gain and muscle loss. In men, low testosterone and visceral adiposity feed each other through a specific mechanism: visceral fat contains aromatase enzyme, which converts testosterone to estradiol, which suppresses pituitary signaling and lowers testosterone production further. The cycle is self-perpetuating, and the patient ends up with progressive central weight gain and progressive testosterone decline that compound each other.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Thyroid is the third pillar. Chronic cortisol elevation impairs the conversion of T4 to active T3 and increases reverse T3, producing what is functionally subclinical hypothyroidism even when the TSH looks normal. The patient is metabolically slowed at the cellular level, and the standard thyroid screen does not catch it.
How I evaluate someone presenting with this picture
When a patient sits down describing the situation I opened with, I am working through a specific differential. The history covers prior weight loss attempts — what was tried, what worked temporarily, what failed, and why the patient thinks it failed. I want a current intake of sleep quality and quantity, alcohol use, caffeine timing, exercise patterns, and stress sources. I want to know what medications and supplements are being used, including SSRIs and beta-blockers and antihistamines that affect metabolic rate and weight regulation in ways that often get ignored. I want a family history of metabolic disease.
The lab panel is comprehensive. Metabolic markers include fasting insulin and HOMA-IR (not just glucose and HbA1c), full lipid panel including ApoB when warranted, and a comprehensive metabolic panel. Hormonal markers include the full sex hormone panel — estradiol, progesterone, total and free testosterone, SHBG, DHEA-S — and the full thyroid panel including reverse T3 and antibodies. Cortisol assessment depends on the picture: a morning serum cortisol is the starting point, with a four-point salivary cortisol curve added when the rhythm itself is in question. Inflammatory and nutritional markers include hs-CRP, ferritin, vitamin D, B12, and magnesium. When body composition is meaningful to the plan, I add a DEXA scan so we know what the weight is actually composed of.
This panel reveals the actual driver in almost every patient who presents with stubborn central weight gain. The "just menopause" answer almost always misses something treatable.
How treatment proceeds
The medical weight loss program at Revitalize is built around addressing all the contributing mechanisms in parallel rather than chasing the symptom alone. The 90-day structured phase is enough time to complete the workup, initiate the interventions, reassess at three months, and build the maintenance framework.
When GLP-1 therapy is appropriate — and for most patients with this picture, it is — it gets initiated at a conservative starting dose with a deliberate titration schedule. GLP-1 medications address several of the mechanisms at once: improved insulin sensitivity, reduced visceral fat, reduced inflammatory markers, appetite suppression. The result for the right candidate is reliable, but only when the rest of the picture is also being addressed.
Hormone optimization, when the panel shows it is warranted, runs in parallel. Estrogen and progesterone restoration in perimenopausal women restores the metabolic terrain that was supporting healthy body composition before the decline started. Testosterone replacement in deficient women supports lean mass and metabolic rate. In men, the same logic applies — testosterone deficiency in the context of visceral adiposity is one of the most leveraged interventions I have. Thyroid support, when the panel shows reverse T3 elevation or genuinely low free T3, can move the needle on its own.
Cortisol regulation is harder than the supplement industry pretends, and I am skeptical of the "take this adaptogen" approach. The interventions that actually work are sleep restoration, deliberate circadian routine, blood sugar stability through protein-forward nutrition timing, resistance training (which improves cortisol regulation as well as insulin sensitivity), and reducing the upstream stressors that are keeping cortisol elevated. Nutritional counseling plays a meaningful role here, because the dietary patterns that stabilize blood sugar and support cortisol regulation are not the same patterns the average patient defaults to.
What the timeline looks like
Realistic expectations matter, because this picture took years to develop and it does not reverse in weeks. Initial improvements in energy, sleep, and appetite show up in the first two to four weeks when the protocol is right. Measurable scale movement is usually noticeable by week six to eight on GLP-1, with the bigger inflection at month three when hormonal interventions have had time to take effect. Body composition changes — losing visceral fat specifically rather than just losing weight — show up best on DEXA at the three- and six-month marks. Full optimization, where the protocol is calibrated and the trajectory is sustainable, is a six-to-twelve-month arc. The patients who do best are the ones who commit to the reassessment cadence, because the protocol that worked at month two often needs adjustment by month six.
The next step if this is your picture
If what I have described matches what you have been dealing with, the next step is a real metabolic and hormonal workup — not another round of "eat less and exercise more." The weight loss assessment is a useful five minutes of self-assessment to do before booking. From there, book a consultation at the Columbus clinic or the Warner Robins clinic and bring whatever prior labs you have. If you have tried GLP-1 before without success, bring that history too — the reasons it underperformed are usually addressable.
The patient I opened with started a layered protocol — semaglutide titrated conservatively, transdermal estradiol with cycled progesterone, low-dose testosterone, vitamin D repletion, and a sleep restoration plan that addressed her cortisol rhythm. Five months in, she had lost 16 pounds, her DEXA showed the loss was almost entirely visceral fat, her fasting insulin had dropped to 7, and her waistline measurements were back where they had been five years earlier. The intervention that worked was the one that addressed the mechanism rather than the symptom.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.